CLSI C62

CLSI C62

Click here to purchase

This document provides guidance to the clinical laboratorian for the reduction of interlaboratory variance and the evaluation of interferences, assay performance, and other pertinent characteristics of clinical assays. This guideline emphasizes particular areas related to assay development and presents a standardized approach for method verification that is specific to mass spectrometry technology. 

Product Details

Published:
06/21/2022
ISBN(s):
9781684401550
Number of Pages:
104
File Size:
1 file , 6.8 MB
Note:
This product is unavailable in Russia, Belarus

You may also like

CLSI VET01S

CLSI VET01S

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 6th Edition, VET01SEd6Estandard by Clinical and...

CLSI EP33

CLSI EP33

Use of Delta Checks in the Medical Laboratory, 2nd Edition, EP33Ed2Estandard by Clinical and Laboratory Standards Institute, 06/01/2023

CLSI EP25-Ed2

CLSI EP25-Ed2

Evaluation of Stability of In Vitro Medical Laboratory Test Reagents, 2nd Edition, EP25Ed2Estandard by Clinical and Laboratory Standards Institute, 04/26/2023

CLSI PRE04

CLSI PRE04

Handling, Transport, Processing, and Storage of Blood Specimens for Routine Laboratory Examinations, 1st Edition, PRE04Ed1Estandard by Clinical and Laboratory Standards...

Back to Top